BMJ Sexual & Reproductive Health is a premier academic journal published by the esteemed BMJ Publishing Group in the United Kingdom. With an ISSN of 2515-1991 and E-ISSN of 2515-2009, this journal stands at the forefront of critical research in the fields of Obstetrics and Gynecology and Reproductive Medicine, reflecting its commitment to delivering high-quality, peer-reviewed content. Recognized for its significant impact, the journal holds a Q1 classification in both disciplines for 2023, with Scopus rankings of 49th in Obstetrics and Gynecology and 26th in Reproductive Medicine, placing it within the top quartiles of these fields. The journal aims to bridge the gap between cutting-edge research and practical application, providing a platform for researchers, professionals, and students to engage with groundbreaking findings and stay updated on best practices in sexual and reproductive health. As an Open Access journal, it ensures that knowledge is freely available to a global audience, further promoting the advancement of science and health care practices.

Revista Brasileira de Ginecologia e Obstetricia is a renowned academic journal based in Brazil, published by GEORG THIEME VERLAG KG, dedicated to advancing research in the fields of gynecology and obstetrics. With an Open Access policy since 1998, this journal ensures that critical findings and insights remain accessible to a global audience, fostering collaboration and knowledge sharing among healthcare professionals and researchers. The journal has maintained a respectable position within its field, currently ranked Q3 in Obstetrics and Gynecology according to the 2023 category quartiles, and holds a Scopus rank of 122 out of 209, placing it in the 41st percentile. Covering a wide array of topics pertinent to women's health, the Revista Brasileira de Ginecologia e Obstetricia serves as a vital platform for disseminating new research, clinical practices, and reviews, contributing to the enhanced understanding and treatment of gynecological and obstetrical conditions. The journal not only supports academic rigor but also empowers professionals and students in their pursuit of excellence in women's health.

International Journal of Women's Health and Reproduction Sciences, published by ARAS PART MEDICAL INT PRESS, stands as a pivotal platform for the dissemination of research and scholarly work in the fields of obstetrics, gynecology, and reproductive health. Established in 2013, this journal aims to advance the understanding of women's health issues and reproductive sciences, fostering a multidisciplinary approach that encourages collaboration amongst healthcare professionals, researchers, and students. With an ISSN of 2330-4456, it operates under a rigorous editorial process that ensures the publication of high-quality research. The journal has been recognized in 2023 with a Q3 ranking in Obstetrics and Gynecology and a Q4 ranking in Reproductive Medicine, indicating its growing influence and the importance of its contributions to the field. Currently, it ranks #128 out of 209 in Obstetrics and Gynecology and #62 out of 90 in Reproductive Medicine on Scopus, positioning it within the global academic discourse. Although it operates without an open access model, its contributions are critical for those dedicated to advancing medical knowledge and practices regarding women's health. For researchers and professionals committed to improving reproductive health care and enhancing women's health outcomes, this journal serves as an essential resource.

Clinical and Experimental Obstetrics & Gynecology is a prominent journal published by IMR PRESS, dedicated to the fields of obstetrics, gynecology, and reproductive medicine. Since its establishment in 1974, this journal has been a crucial platform for the dissemination of research findings, innovative practices, and reviews that contribute to the advancement of women's health. With an Open Access model adopted in 2019, it ensures that high-quality research is accessible to all stakeholders in the field, thus promoting greater collaboration and knowledge sharing. Based in Hong Kong, the journal is indexed under various categories with a 2023 Quartile ranking of Q3 in Obstetrics and Gynecology and Q4 in Reproductive Medicine, affirming its role in shaping the academic conversation within these disciplines. Despite its current Scopus rankings placing it in the lower percentiles, the journal continues to grow in influence, making it an essential resource for researchers, healthcare professionals, and students aiming to stay at the forefront of clinical and experimental innovations in obstetrics and gynecology.

Sexual and Reproductive Health Matters is an esteemed open-access journal published by Taylor & Francis Ltd, dedicated to advancing the fields of obstetrics and gynecology as well as reproductive medicine. Since its transition to open access in 2019, the journal has provided a vital platform for disseminating cutting-edge research and innovative practices pertaining to sexual and reproductive health. With a commendable impact reflected by its categorization in the Q1 Quartile for both Obstetrics and Gynecology and Reproductive Medicine as per the 2023 rankings, it ranks prominently at #71 out of 209 in Obstetrics and Gynecology and #34 out of 90 in Reproductive Medicine on Scopus. This journal not only serves as a resource for researchers and practitioners in the United Kingdom but also has a global reach, inviting contributions that address critical issues related to sexual and reproductive health. Positioned at the forefront of current health science discourse, Sexual and Reproductive Health Matters is an essential read for anyone dedicated to improving health outcomes in this vital area.

The International Journal of Reproductive Biomedicine, an esteemed publication by SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES, serves as a pivotal platform in the fields of obstetrics and gynecology as well as reproductive medicine. Established in 2011 and transitioning to an open access model in 2015, this journal facilitates the dissemination of innovative research and critical findings to a global audience, particularly focusing on advancements in reproductive health and biomedicine. With an impact factor reflective of its commitment to high-quality scientific inquiry, the journal has achieved a notable ranking of Q3 in both its categories for 2023, contributing to its growing influence within the academic community. Researchers and professionals benefit from its broad scope, which encompasses a range of topics essential to reproductive health, thus fostering a rich exchange of knowledge. The journal's accessibility allows students and professionals alike to engage with the latest findings and contribute to ongoing discussions within this vital field of study.

Obstetrics and Gynecology International is a premier, peer-reviewed journal published by HINDAWI LTD, dedicated to advancing the fields of obstetrics and gynecology. With an open access model established in 2009, this journal ensures that research findings are freely accessible to all, significantly contributing to the global dialogue in women's health. As of 2023, the journal holds a respectable Q3 ranking in the Obstetrics and Gynecology category and is positioned in the 60th percentile among its peers in the Scopus indexing, highlighting its impact in the field. The journal addresses a broad spectrum of topics relevant to both clinical practitioners and researchers, fostering an interdisciplinary approach to maternal and reproductive health. With a commitment to the dissemination of innovative research and evidence-based practices, Obstetrics and Gynecology International serves as an essential resource for professionals eager to stay abreast of ongoing developments and enhance their understanding of complex issues in women's health.

Zeitschrift für Sexualforschung, published by GEORG THIEME VERLAG KG, is a prominent journal based in Germany that specializes in the multifaceted fields of psychology and reproductive medicine. With an ISSN of 0932-8114 and an E-ISSN of 1438-9460, this journal serves as a crucial platform for disseminating research and advancements in sexual science. It occupies a notable position, ranked in the Q4 category in Psychology (miscellaneous) and Q3 in Reproductive Medicine as of 2023. Despite being categorized in the lower quartiles, the journal's contributions remain essential for understanding the complexities of human sexuality and reproductive health. Its convergence period spanning from 2008 to 2024 signifies a sustained commitment to advancing knowledge in these fields. Researchers, professionals, and students are encouraged to engage with the journal's content to stay informed on contemporary issues, trends, and innovative research in sexual health, enhancing the discourse surrounding psychological and reproductive topics.

Frontiers in Reproductive Health is a leading open-access journal published by Frontiers Media SA in Switzerland, dedicated to advancing the field of reproductive health through high-quality research and comprehensive reviews. With a commitment to fostering an interdisciplinary dialogue, this journal covers an array of topics including epidemiology, family practice, obstetrics and gynecology, and reproductive medicine. As of 2023, it ranks in the Q3 quartile in Epidemiology, Q1 in Family Practice, and Q2 in both Obstetrics and Gynecology and Reproductive Medicine, reflecting its significance and growing influence in these areas. Researchers and professionals can benefit from the journal's wide distribution and open access policy, which facilitates the sharing of knowledge and enhances the visibility of their work. By embracing innovative studies and harnessing the talents of both established scholars and emerging voices, Frontiers in Reproductive Health plays a crucial role in shaping the future of reproductive health research and practice.

Therapeutic Advances in Reproductive Health, published by SAGE Publications Ltd, is an esteemed open-access journal dedicated to the field of reproductive health, with an E-ISSN of 2633-4941. Launched in 2020, the journal aims to disseminate cutting-edge research, novel therapeutic methodologies, and clinical applications related to reproductive health challenges. With an unwavering commitment to enhancing patient outcomes and advancing scientific understanding, it serves as a vital resource for researchers, healthcare professionals, and students alike. The journal emphasizes rigorous peer-reviewed content, ensuring high-quality publications that contribute significantly to the academic community. In an era where access to crucial health information is paramount, this open-access platform not only broadens the reach of research but also fosters collaboration and innovation in reproductive health.